Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHIDIAS: Prevention of Hypertension and Diabetes in Metabolic Syndrome
NCT00456963Phase 4Terminated
- Sponsor
- Istituto Auxologico Italiano
- Start
- Sep 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of enalapril, losartan in hypertension (HTN), type 2 diabetes mellitus (T2DM), sponsored by Istituto Auxologico Italiano. Started Sep 2007; status: terminated.
02
Drugs
enalaprillosartan
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00456963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456963.